Characterization and Biomarker Analyses of Post-COVID-19 Complications and Neurological Manifestations.
Characterization and Biomarker Analyses of Post-COVID-19 Complications and Neurological Manifestations.
复制标题
DOI:
10.3390/cells10020386
复制
发表时间:
2021-02-13
期刊:
影响因子:
6
通讯作者:
Pulliam L
中科院分区:
文献类型:
--
作者:
Sun B;Tang N;Peluso MJ;Iyer NS;Torres L;Donatelli JL;Munter SE;Nixon CC;Rutishauser RL;Rodriguez-Barraquer I;Greenhouse B;Kelly JD;Martin JN;Deeks SG;Henrich TJ;Pulliam L
As the SARS-CoV-2 pandemic continues, reports have demonstrated neurologic sequelae following COVID-19 recovery. Mechanisms to explain long-term neurological sequelae are unknown and need to be identified. Plasma from 24 individuals recovering from COVID-19 at 1 to 3 months after initial infection were collected for cytokine and antibody levels and neuronal-enriched extracellular vesicle (nEV) protein cargo analyses. Plasma cytokine IL-4 was increased in all COVID-19 participants. Volunteers with self-reported neurological problems (nCoV, n = 8) had a positive correlation of IL6 with age or severity of the sequalae, at least one co-morbidity and increased SARS-CoV-2 antibody compared to those COVID-19 individuals without neurological issues (CoV, n = 16). Protein markers of neuronal dysfunction including amyloid beta, neurofilament light, neurogranin, total tau, and p-T181-tau were all significantly increased in the nEVs of all participants recovering from COVID-19 compared to historic controls. This study suggests ongoing peripheral and neuroinflammation after COVID-19 infection that may influence neurological sequelae by altering nEV proteins. Individuals recovering from COVID-19 may have occult neural damage while those with demonstrative neurological symptoms additionally had more severe infection. Longitudinal studies to monitor plasma biomarkers and nEV cargo are warranted to assess persistent neurodegeneration and systemic effects.
登录
查看更多内容
影响因子:
12.3
作者:
Huang, Da Wei;Sherman, Brad T;Tan, Qina;Collins, Jack R;Alvord, W Gregory;Roayaei, Jean;Stephens, Robert;Baseler, Michael W;Lane, H Clifford;Lempicki, Richard A
通讯作者:
Lempicki, Richard A
DOI:
10.1016/j.ijid.2020.10.044
发表时间:
2021-01
期刊:
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
影响因子:
--
作者:
Espíndola OM;Brandão CO;Gomes YCP;Siqueira M;Soares CN;Lima MASD;Leite ACCB;Torezani G;Araujo AQC;Silva MTT
通讯作者:
Silva MTT
影响因子:
82.9
作者:
Del Valle DM;Kim-Schulze S;Huang HH;Beckmann ND;Nirenberg S;Wang B;Lavin Y;Swartz TH;Madduri D;Stock A;Marron TU;Xie H;Patel M;Tuballes K;Van Oekelen O;Rahman A;Kovatch P;Aberg JA;Schadt E;Jagannath S;Mazumdar M;Charney AW;Firpo-Betancourt A;Mendu DR;Jhang J;Reich D;Sigel K;Cordon-Cardo C;Feldmann M;Parekh S;Merad M;Gnjatic S
通讯作者:
Gnjatic S
影响因子:
9.9
作者:
Lin, Chin-Hsien;Li, Cheng-Hsuan;Chiu, Ming-Jang
通讯作者:
Chiu, Ming-Jang
影响因子:
5.3
作者:
Goetzl EJ;Boxer A;Schwartz JB;Abner EL;Petersen RC;Miller BL;Carlson OD;Mustapic M;Kapogiannis D
通讯作者:
Kapogiannis D